#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cryoglobulinaemia Cognitive disorder Leukocyte adhesion deficiency type I Aplastic anaemia Angiosarcoma Pemphigus Arteriovenous malformation Inflammatory myofibroblastic tumour Frostbite Malignant central nervous system neoplasm Pulmonary hypertension Hyperadrenocorticism Growth hormone deficiency Leukocyte adhesion deficiency Gaucher's disease type I More trials…

    Learn about Rare Diseases

    Chondrosarcoma metastatic – Trials in Disease Richter’s syndrome – Basic Information Soft tissue sarcoma – Trials in Disease Angiosarcoma non-metastatic Idiopathic pulmonary fibrosis – Life with Disease Testicular leiomyosarcoma – Trials in Disease Leiomyosarcoma metastatic – Trials in Disease Hairy cell leukaemia – Life with Disease Familial amyotrophic lateral sclerosis Hereditary neuropathic amyloidosis – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Amphotericine B, Liposome Ruxolitinib Natalizumab EGANELISIB Navitoclax Albumin BW-20805 Fosfomycin Canis Familiaris (553) HSP-CAR19M Zinc Sulphate Heptahydrate Gr0015 Baclofen Enfortumab Vedotin Jnj-81241459 Benserazide Hydrochloride Deucravacitinib Divarasib MZE829 Vortioxetine Hydrobromide More therapies…

    Learn about Your Condition

    Primary hyperaldosteronism Ophthalmoplegia Malignant melanoma stage III Hand dermatitis Dry eye Procedural anxiety Ocular hypertension Adrenoleukodystrophy Hypertonic bladder Tourette's disorder Pulmonary venous thrombosis Injection site pain Ataxia telangiectasia Skin cancer Migraine with aura More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Complications of transplanted heart

  • Study of belatacept, tacrolimus and ciclosporin in heart transplant patients at risk of kidney failure

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Complications of transplanted heart
    Investigated Drugs:
    • Belatacept
    • Ciclosporin
    • Tacrolimus
    France

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!